Cell therapy companies make strong progress from October 2012 to March 2013 amid mixed stock market sentiment.
During Q4 2012 and Q1 2013, the cell therapy industry made strong progress in translation and commercialization. Continued development of the companies included in a dedicated stock market index suggests emergence of this industry as a distinct healthcare sector.